New Issue: Orbital Catastrophe Ahead? Read Now

Tests Confirm Pablo Neruda Had Terminal Cancer

The Chilean poet had prostate cancer in an advanced state, with extended metastasis, according to an analysis of his remains

Join Our Community of Science Lovers!

Originally posted on the Nature news blog

At the moment of his death, Chilean poet Pablo Neruda had a prostate cancer in advanced state, with extended metastasis, according to the first analysis of his remains, carried on by the Chilean Legal Medical Service (SML). The results were delivered yesterday to Mario Carroza, the prosecution judge who is investigating the cause of the Nobel Laureate’s death in 1973.

Whether the death was caused by that cancer, or rather by poisoning, as a key witness has claimed, may be cleared by a toxicological analysis that is being carried on in North Carolina.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Neruda’s body was unearthed from his tomb in Isla Negra, Chile, in early April, as part of an investigation opened after Neruda’s former driver Manuel Araya said that the real cause of the poet’s death was an unscheduled injection that he received a few hours before dying.

The first set of analyses included histological and radiological tests. The SML declined to provide more details but the Chilean newspaper El Mercurio said the experts’ team has found “irregular destruction” and osteonecrosis in bone fragments of the dorsal and lumbar vertebrae, features of the bone metastasis that appear in advanced prostate cancer.

This article is reproduced with permission from the magazine Nature and the Nature news blog. The article was first published on May 7, 2013.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe